**UNITED
      STATES**


**SECURITIES
      AND EXCHANGE COMMISSION**


Washington
      D. C. 20549





**FORM
      10-QSB**





**QUARTERLY
      REPORT UNDER SECTION 13 or 15 (d)**


**OF
      THE SECURITIES EXCHANGE ACT OF 1934**





For
      the
      quarterly period ended March 31, 2007


*Commission
      file number 000-29461*





**Organetix,
      Inc.**


(Exact
      name of small business issuer as specified in its charter)





Delaware
            73-1556428(State
                or other jurisdiction of
              incorporation
                or organization)
            (I.R.S.
                Employer
              Identification
                No.)





405
      Park
      Avenue - 15 th Floor,
      New York, New York 10022


(Address
      of principal executive offices) (Zip Code)


Issuer's
      telephone number: (440) 759-7470


(Address
      of principal executive offices)


Suite
      200, 603 - 7 th Avenue
      S.W., Calgary, Alberta, Canada T2P 2T5


(Former
      name, former address and former fiscal year, if changed since last
      report.)




Check
      whether the issuer (1) has filed all reports required to be filed by Section
      13
      or 15(d) of the Exchange Act during the past 12 months (or for such shorter
      period that the registrant was required to file such reports), and (2) has
      been
      subject to such filing requirements for the past 90 days. Yes x   No  o




State
      the
      number of shares outstanding of each of the issuer's classes of common equity,
      as of the latest practicable date.




The
      number of shares of the issuer’s outstanding common stock, which is the only
      class of its common equity, on March 31, 2007, was 72,515,780.




1





**ORGANETIX,
      INC.**


**A
      Development Stage Company**




PAGE(S)




**PART
                I FINANCIAL INFORMATION**Item
                1.
            Financial
                Statements:Balance
                Sheets - March 31, 2007 and December 31, 2006
            3.Statements
                of Operations - Three months ended March 31, 2007 and 2006 and the
                Period
                from Inception (May 28, 2003) to March 31, 2007
            4.Statements
                of Cash Flows - Three months ended March 31, 2007 and 2006 and the
                Period
                from Inception (May 28, 2003) to March 31, 2007
            5.Notes
                to Interim Financial Statements
            6.Item
                2.
            Management’s
                Discussion and Analysis of Financial Condition and Results of
                Operations
            9.Item
                3.
            Controls
                and Procedures
            11.**PART
                II**
            **OTHER
                INFORMATION**Signatures
            14.Exhibits
            15.


2


**PART
      1 - FINANCIAL INFORMATION**





**ITEM
      1 - FINANCIAL STATEMENTS**





ORGANETIX,
      INC.


(A
      Development Stage Company)


BALANCE
      SHEETS








March
                31,
              2007
            
            December
                31,
              2006(Unaudited)ASSETSCURRENT
                ASSETSPrepaid
                expenses
            
            $
            75,185
            
            $Total
                Current Assets
            
            $
            75,185Total
                Assets
            
            $
            75,185
            
            $LIABILITIES
                AND STOCKHOLDERS’ EQUITYTOTAL
                LIABILITIES
            
            $
            
            
            $STOCKHOLDERS’
                EQUITYCommon
                stock, par value $0.0001, authorized150,000,000
                shares, issued and outstanding72,515,780
                and 62,882,447 at March 31, 2007and
                December 31, 2006, respectively
            
            
            7,251
            
            $
            6,288Additional
                paid in capital
            
            
            4,350,486
            
            
            4,012,449Deficit
                accumulated during the developmental stage
            
            
            (4,282,552
            )
            
            (4,018,737
            )Total
                Stockholders’ Equity
            
            
            75,185Total
                Liabilities and Stockholders’ Equity
            
            $
            75,185
            
            $







See
      accompanying notes to financial statements.


3


ORGANETIX,
      INC.


(A
      Development Stage Company)


STATEMENTS
      OF OPERATIONS (Unaudited)


For
                  the PeriodThree
                  Months Ended
              
              From
                  InceptionMarch
                  31,
              
              (May
                  28, 2003) to2007
              
              2006
              
              March
                  31, 2007COSTS
                  AND EXPENSESOperating
                  expenses-research facility
              
              
              
              
              $
              18,600
              
              $
              247,659Research
                  and development expenses
              
              $
              204,000
              
              
              66,139
              
              
              1,468,156Consulting
                  fees
              
              
              12,315
              
              
              45,000
              
              
              540,843Professional
                  fees
              
              
              48,058
              
              
              11,380
              
              
              413,854Travel
                  and accommodations
              
              
              
              
              
              3,532
              
              
              130,364Telephone
              
              
              
              
              
              2,252
              
              
              35,528Interest
                  expense
              
              
              
              
              
              7,530
              
              
              52,670Insurance
              
              
              
              
              
              11,326
              
              
              104,188Rent
              
              
              
              
              
              3,701
              
              
              42,410Shipping
                  expense
              
              
              
              
              
              786
              
              
              6,184Office
                  and other expense
              
              
              
              
              
              14,031
              
              
              167,775Marketing
                  and public relations
              
              
              
              
              
              426
              
              
              271,899Depreciation
                  and amortization expense
              
              
              
              
              
              16,188
              
              
              208,719Loss
                  on disposition of assets
              
              
              
              
              
              
              
              
              592,861Total
                  Cost and Expenses
              
              
              264,373
              
              
              200,891
              
              
              4,283,110OTHER
                  INCOMEInterest
                  income
              
              
              558
              
              
              
              
              
              558NET
                  LOSS
              
              $
              (263,815
              )
              $
              (200,891
              )
              $
              4,282,552NET
                  LOSS PER COMMON SHARE(Basic
                  and Diluted)
              
              $
              (0.01
              )
              $
              (0.01
              )
              $
              (0.05
              )WEIGHTED
                  AVERAGE SHARESOUTSTANDING
              
              
              58,079,271
              
              
              86,382,447
              
              
              78,971,484











See
      accompanying notes to financial statements.


4


ORGANETIX,
      INC.


(A
      Development Stage Company)


STATEMENTS
      OF CASH FLOWS (Unaudited)


For
                  the PeriodThree
                  Months Ended
              
              From
                  InceptionMarch
                  31,
              
              (May
                  28, 2003) to2007
              
              2006
              
              March
                  31, 2007CASH
                  FLOWS FROM OPERATING ACTIVITIESNet
                  loss
              
              $
              (263,815
              )
              $
              (200,891
              )
              $
              (4,282,552
              )Adjustments
                  to reconcile net loss to net cashprovided
                  by operating activities:Depreciation
                  and amortization
              
              
              
              
              
              16,188
              
              
              208,719Loss
                  on disposition of assets
              
              
              
              
              
              
              
              
              592,861Compensatory
                  shares
              
              
              
              
              
              
              
              
              324,111Amortization
                  of prepaid consulting
              
              
              4,815
              
              
              
              
              
              4,815Changes
                  in assets and liabilities:(Increase)
                  decrease in prepaid expenses
              
              
              
              
              
              11,315
              
              
              (43,414
              )Increase
                  in accounts payable
              
              
              
              
              
              69,863
              
              
              354,156Increase
                  in accrued salaries to officers
              
              
              
              
              
              75,000
              
              
              708,966Increase
                  in due to shareholders
              
              
              
              
              
              19,612
              
              
              204,273Increase
                  in accrued interest
              
              
              
              
              
              7,396
              
              
              28,239Net
                  cash used in operating activities
              
              
              (259,000
              )
              
              (1,517
              )
              
              (1,899,826
              )CASH
                  FLOWS FROM INVESTING ACTIVITIESPayment
                  regarding license
              
              
              
              
              
              
              
              
              (150,000
              )Capital
                  expenditures
              
              
              
              
              
              
              
              
              (30,000
              )Net
                  cash used in investing activities
              
              
              
              
              
              
              
              
              (180,000
              )CASH
                  FLOWS FROM FINANCING ACTIVITIESIssuance
                  of common stock to founders
              
              
              
              
              
              
              
              
              65,760Issuance
                  of common stock in private placement
              
              
              259,000
              
              
              
              
              
              259,000Additional
                  contribution of capital
              
              
              
              
              
              
              
              
              1,288,866Issuance
                  of note receivable
              
              
              (100,000
              )
              
              
              
              
              (100,000
              )Repayment
                  of note receivable
              
              
              100,000
              
              
              
              
              
              100,000Cash
                  received in merger
              
              
              
              
              
              
              
              
              300,000Convertible
                  note payable
              
              
              
              
              
              
              
              
              150,000Note
                  payable to individual
              
              
              
              
              
              
              
              
              16,200Net
                  cash provided by financing activities
              
              
              259,000
              
              
              
              
              
              2,079,826DECREASE
                  IN CASH
              
              
              
              
              
              (1,517
              )CASH
                  AT BEGINNING OF PERIOD
              
              
              
              
              
              3,279CASH
                  AT END OF PERIOD
              
              $
              
              
              $
              1,762
              
              $SUPPLEMENTAL
                  DISCLOSURES OF CASH FLOWINFORMATIONNON-CASH
                  FINANCING ACTIVITIESCancellation
                  of common stock
              
              
              
              
              
              
              
              
              2,350





See
      accompanying notes to financial statements.


5


ORGANETIX,
      INC.


(A
      Development Stage Company)


NOTES
      TO
      FINANCIAL STATEMENTS (Unaudited)


MARCH
      31,
      2007





NOTE
      1 -
      DESCRIPTION OF COMPANY/OPERATIONS, GOING CONCERN AND CHANGE OF
      CONTROL





Organetix,
      Inc. ("the Company" or "Organetix"), a Delaware Corporation, was incorporated
      on
      May 28, 2003.





Organetix
      was a biotechnology company with an exclusive worldwide license for the formula
      of a proprietary medical discovery relating to the liver referred to as A4+L.





On
      November 7, 2003 (the "Effective Date"), pursuant to a Share Exchange Agreement
      ("Agreement") between Diamond International Group, Inc. ("Diamond"), a Delaware
      corporation and Organetix, Inc. ("Organetix"), a Delaware corporation and all
      of
      the shareholders of Organetix, Diamond acquired all of the shares of Organetix
      as consideration for the issuance of 64,000,000 restricted shares of Diamond
      to
      the Organetix shareholders. As a result of this Agreement, Diamond International
      Group, Inc. (the legal acquirer) received 100% of the issued and outstanding
      common stock of Organetix, Inc. in exchange for 64,000,000 shares of common
      stock of Diamond. Pursuant to the Agreement, Organetix became a wholly owned
      subsidiary of Diamond which entity filed a Certificate of Amendment with the
      State of Delaware changing its name to Organetix, Inc. This reverse merger
      transaction was treated retroactively as a recapitalization with Organetix,
      Inc.
      being treated as the accounting acquirer.





Previously,
      the Company devoted its time towards establishing its business and no revenues
      have been generated to date. As such, the Company is considered as being in
      the
      development stage, since its inception, in accordance with Statement of
      Financial Accounting Standards No. 7, and its year-end is December
      31.





Change
      in Control:





On
      August
      18, 2006, AMMA Corporation and other shareholders entered into a stock purchase
      agreement with Lusierna Asset Management, as agent for various purchasers
      ("Stock Purchase Agreement"), whereby AMMA Corporation shall sold 51,546,000
      shares of the Company's common stock. The closing of the Stock Purchase
      Agreement resulted in a change of control. As consideration for the shares
      and
      the assumption of all liabilities of the Company, AMMA Corporation received
      (i)
      cash and (ii) an assignment of certain assets of the Company. The Company did
      not receive any sales proceeds or other consideration in connection with this
      transaction. As a result of this change of control, the Company cancelled
      23,500,040 shares of its common stock. The Company also released or paid in
      cash
      its outstanding liabilities in exchange for the rights to the Company’s
      licensing agreement. Accordingly, a $592,861 loss was recorded on the
      disposition of these assets and liabilities.





Going
      Concern:





As
      shown
      in the accompanying financial statements, the Company has incurred net losses
      of
      $4,282,552 since inception. Management's plans include raising of capital
      through the equity markets to fund operations, and the generating of revenue
      through its business. Failure to raise adequate capital and generate adequate
      sales revenues could result in the Company having to curtail or cease
      operations. Additionally, even if the Company does raise sufficient capital
      to
      support its operating expenses and generate adequate revenues, there can be
      no
      assurances that the revenue will be sufficient to enable it to develop to a
      level where it will generate profits and cash flows from operations. These
      matters raise substantial doubt about the Company's ability to continue as
      a
      going concern. However, the accompanying financial statements have been prepared
      on a going concern basis, which contemplates the realization of assets and
      satisfaction of liabilities in the normal course of business. These financial
      statements do not include any adjustments relating to the recovery of the
      recorded assets or the classifications of the liabilities that might be
      necessary should the Company be unable to continue as a going
      concern.


6


ORGANETIX,
      INC.


(A
      Development Stage Company)


NOTES
      TO
      FINANCIAL STATEMENTS (Unaudited)


MARCH
      31,
      2007





NOTE
      2-
      NEW ACCOUNTING PRONOUNCEMENTS





In
      June 2006, the Financial Accounting Standards Board (“FASB”) issued
      Interpretation 48, “Accounting for Income Tax Uncertainties” (“FIN 48”). FIN 48
      defines the threshold for recognizing the benefits of tax return positions
      in
      the financial statements as “more-likely-than-not” to be sustained by the taxing
      authority. Recently issued literature also provides guidance on the
      derecognition, measurement and classification of income tax uncertainties,
      along
      with any related interest and penalties. FIN 48 also includes guidance
      concerning accounting for income tax uncertainties in interim periods and
      increases the level of disclosures associated with any recorded income tax
      uncertainties. FIN 48 is effective for fiscal years beginning after
      December 15, 2006. The Company adopted the provisions of FIN 48 in the
      first quarter of 2007. Adoption of FIN 48 did not have a material impact on
      the
      Company’s financial statements.





NOTE
      3 -
      SHAREHOLDERS' EQUITY:





During
      the three months ended March 31, 2007, the Company sold 8,633,333 shares of
      its
      common stock at $0.03 in a private placement and received proceeds of $259,000.





NOTE
      4 -
      LOAN TO UNIPIXEL





In
      January of 2007, the Company loaned $100,000 to Unipixel. This loan plus accrued
      interest was repaid on February 15, 2007.





NOTE
      5-
      AGREEMENT WITH VOLIUS, INC.





On
      September 26, 2006, the Company entered into a letter of intent with Volius,
      Inc. ("Volius") to acquire all of Volius' assets in exchange for 50.5% of the
      company's shares of common stock or approximately 63,511,270 shares.
      Contemporaneous with the effectiveness of the merger, the Company was required
      to raise between $4 and $6 million dollars to fund the operations of the newly
      merged company on mutually agreeable terms.





On
      January 18, 2007, the Company terminated its Letter of Intent to merge with
      Volius because the Company and Volius could not agree on the amount of capital
      to be raised, the valuation of Volius, and the timing of the ultimate
      transaction.





NOTE
      6-
      AGREEMENT WITH ADAO TELECOM, INC.





On
      January 24, 2007, Organetix executed a definitive agreement to acquire
      ADAO.  ADAO is a telephony engineering and design firm specializing in the
      development of cellular technologies that target the low-end user market
      segment.  The transaction is expected to close in the 2 nd calendar
      quarter of 2007 (“Closing”). Under the terms of the agreement, the Company is
      required to invest an aggregate of $300,000 in ADAO prior to the closing, which
      shall be used specifically to develop a prototype to be owned by the Company.
      Upon successful completion of the prototype and other conditions in the proposed
      exchange transaction, at Closing, the Company will issue 73,500,000 ($.0001
      par
      value per share) restricted shares of common stock of the Company equal to
      53.5%
      of the outstanding shares of common stock to the shareholders of ADAO. As
      further consideration, the Company has agreed that, subsequent to Closing,
      it
      will increase its authorized number of shares of common stock from
      150,000,000 to 300,000,000 and change its name to ADAO Wireless, Inc. ADAO
      will then receive an additional 17,000,000 shares of the Company’s common stock.





7


ORGANETIX,
      INC.


(A
      Development Stage Company)


NOTES
      TO
      FINANCIAL STATEMENTS (Unaudited)


MARCH
      31,
      2007





NOTE
      6-
      AGREEMENT WITH ADAO TELECOM, INC. (CONTINUED)





During
      the three months ended March 31, 2007, the Company transferred $204,000 to
      ADAO
      as part of the agreement. This payment is included with Research and Development
      Expenses on the Consolidated Statement of Operations.





















8


**ITEM
      2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
      OF
      OPERATIONS**





**CAUTIONARY
      STATEMENT REGARDING FORWARD LOOKING STATEMENTS**


It
      should
      be noted that this Management's Discussion and Analysis of Financial Condition
      and Results of Operations may contain "forward-looking statements." The terms
      "believe," "anticipate," "intend," "goal," "expect," and similar expressions
      may
      identify forward-looking statements. These forward-looking statements represent
      the Company's current expectations or beliefs concerning future events. The
      matters covered by these statements are subject to certain risks and
      uncertainties that could cause actual results to differ materially from those
      set forth in the forward-looking statements, including the Company's dependence
      on weather-related factors, introduction and customer acceptance of new
      products, the impact of competition and price erosion, as well as supply and
      manufacturing restraints and other risks and uncertainties. The foregoing list
      should not be construed as exhaustive, and the Company disclaims any obligation
      subsequently to revise any forward-looking statements to reflect events or
      circumstances after the date of such statements, or to reflect the occurrence
      of
      anticipated or unanticipated events. In light of the significant uncertainties
      inherent in the forward-looking information included herein, the inclusion
      of
      such information should not be regarded as a representation that the strategy,
      objectives or other plans of the Company will be achieved. The Company wishes
      to
      caution readers not to place undue reliance on any such forward-looking
      statements, which speak only as of the date made.





On
      January 24, 2007, Organetix executed a definitive agreement to acquire
      ADAO.  ADAO is a telephony engineering and design firm specializing in the
      development of cellular technologies that target the low-end user market
      segment.  The transaction is expected to close in the 2 nd calendar
      quarter of 2007 (“Closing”). Under the terms of the agreement, the Company is
      required to invest an aggregate of $300,000 in ADAO prior to the closing, which
      shall be used specifically to develop a prototype to be owned by the Company.
      Upon successful completion of the prototype and other conditions in the proposed
      exchange transaction, at Closing, the Company will issue 73,500,000 ($.0001
      par
      value per share) restricted shares of common stock of the Company equal to
      53.5%
      of the outstanding shares of common stock to the shareholders of ADAO. As
      further consideration, the Company has agreed that, subsequent to Closing,
      it
      will increase its authorized number of shares of common stock from
      150,000,000 to 300,000,000 and change its name to ADAO Wireless, Inc. ADAO
      will then receive an additional 17,000,000 shares of the Company’s common stock.





In
      January of 2007, the Company loaned $100,000 to Unipixel. This loan plus accrued
      interest was repaid on February 15, 2007.




On
      February 15, 2007, Organetix entered into non-exclusive agreements with
      Ambassador Thomas Graham, Jr., Mr. David Lewis and Mr. Aaron Foley to serve
      on
      the Co mpany’s
      Board of Advisors. However, subsequent to that date, Ambassador Graham and
      the
      Company mutually agreed to terminate that agreement and as a result, Ambassador
      Graham is not a member of the Company’s Board of Advisors. Thus, the Company’s
      Board of Advisors consists of Messrs. Lewis and Foley and each shall serve
      until
      the earlier of February 15, 2009 or the date that either Advisor is removed
      from
      the Board. As compensation for participation on the Board of Advisors, each
      member received 500,000 shares of the Company’s common stock.




During
      the three months ended March 31, 2007, the Company transferred $204,000 to
      ADAO
      as part of the agreement. This payment is included with Research and Development
      Expenses on the Consolidated Statement of Operations.





**RESULTS
      OF OPERATIONS**





Operating
      costs for the period from inception to March 31, 2007 aggregated $4,283,110.
      This includes costs incurred in research and development of $1,468,156,
      operating expenses for loss on disposition of assets of $592,861 and consulting
      fees of $540,843. As a result of the above we realized a net loss of $4,283,110
      for the period from inception to March 31, 2007.





Operating
      costs for the three-month period ended March 31, 2006 aggregated $200,891.
      This
      includes research and development expenses of $66,139, operating
      expenses-research facility of $18,600 and consulting fees of $45,000.


9


As
      a
      result of the above we realized a net loss of $(200,891) for the three-month
      period ended March 31, 2006.





Operating
      costs for the three-month period ended March 31, 2007 aggregated $264,373.
      This
      includes the following expenses related to the ADAO exchange transaction:
      research and development expenses of $204,000, professional fees of $48,058
      and
      consulting fees of $12,315. As a result of the above we realized a net loss
      of
      $(263,815) for the three-month period ended March 31, 2007.





For
      the
      period from inception (May 28, 2003) to March 31, 2007, net cash used to fund
      operating activities totaled $(1,899,826), net cash used in investing activities
      totaled $(180,000) and net cash provided by financing activities totaled
      $2,079,826.





For
      the
      three month period ended March 31, 2006, net cash used to fund operating
      activities totaled $(1,517). During this period, no net cash was used in
      investing activities and no net cash was provided by financing activities.





For
      the
      three month period ended March 31, 2007, net cash used to fund operating
      activities totaled $(259,000) and net cash provided by financing activities
      totaled $259,000. During this period, no net cash was used in investing
      activities. As of March 31, 2007, there was no cash on hand.





**FUND
      RAISING ACTIVITIES**


Commencing
      January 11, 2007, the Company began selling shares of its common stock for
      $0.03
      per share. To date, the Company has sold 11,133,333 shares for a total of
      $334,000. The Company plans on raising an additional $75,000, the terms of
      which
      have yet to be determined.





**HISTORY**


Prior
      to
      November 7, 2003, Organetix, Inc. (the “Company”) was in the direct mail
      business and was named Diamond International Group, Inc. However, on such date,
      pursuant to a share exchange agreement among Diamond, Organetix, Inc. and all
      of
      the shareholders of Organetix (“Exchange Agreement"), Diamond acquired all of
      the shares of Organetix, Inc. from its shareholders in consideration for the
      issuance of 64,000,000 restricted shares of Diamond to the Organetix, Inc.
      shareholders (this transaction is referred to herein as the “Exchange”).
      Pursuant to the Exchange Agreement: (i) Organetix, Inc. became a wholly-owned
      subsidiary of Diamond; (ii) and Diamond divested itself of all of its
      pre-Exchange assets to the pre-Exchange shareholders; (iii) Diamond changed
      its
      name to Organetix, Inc.; (iv) Diamond changed its symbol to “OGTX.OB”; and (v)
      Sylvio Martini resigned as the sole director and officer of the Company and
      L.B.
      (Brad) Clarke was appointed to the Board of Directors and named as President,
      President and Chief Financial Officer of Diamond. On August 16, 2006, Mr. Clarke
      appointed David F. Hostelley to the Board and subsequently resigned from all
      officer and director positions. The present company shall sometimes be referred
      to as Organetix or the Company.





**LEGAL
      PROCEEDINGS**


The
      Company is not a party to any material pending legal proceedings or government
      actions, including any bankruptcy, receivership, or similar proceedings.
      Management of the Company does not believe that there are any proceedings to
      which any director, officer, or affiliate of the Company, any owner of record
      of
      the beneficially or more than five percent of the common stock of the Company,
      or any associate of any such director, officer, affiliate of the Company, or
      security holder is a party adverse to the Company or has a material interest
      adverse to the Company.





**CRITICAL
      ACCOUNTING POLICIES AND ESTIMATES**


The
      Company’s discussion and analysis of its financial condition and results of
      operations are based upon its financial statements, which have been prepared
      in
      accordance with accounting principles generally accepted in the United States.
      The preparation of these financial statements requires the Company to make
      estimates and judgments that affect the reported amounts of assets, liabilities,
      revenues and expenses, and related disclosure of contingent assets and
      liabilities. On an on-going basis, the Company evaluates its estimates,
      including those related to bad debts, income taxes and contingencies and
      litigation. The Company bases its estimates on historical experience and on
      various other assumptions that are believed to be reasonable under the
      circumstances, the results of which form the basis for making judgments about
      carrying values of assets and liabilities that are not readily apparent from
      other sources. Actual results may differ from these estimates under different
      assumptions or conditions.




10


***RECENT
      ACCOUNTING PRONOUNCEMENTS AFFECTING THE COMPANY***


In
      June 2006, the Financial Accounting Standards Board (“FASB”) issued
      Interpretation 48, “Accounting for Income
      Tax Uncertainties” (“FIN 48”). FIN 48 defines the threshold for recognizing the
      benefits of tax return positions in the financial statements as
“more-likely-than-not” to be sustained by the taxing authority. Recently issued
      literature also provides guidance on the derecognition, measurement and
      classification of income tax uncertainties, along with any related interest
      and
      penalties. FIN 48 also includes guidance concerning accounting for income tax
      uncertainties in interim periods and increases the level of disclosures
      associated with any recorded income tax uncertainties. FIN 48 is effective
      for
      fiscal years beginning after December 15, 2006. The Company expects to
      adopt the provisions of FIN 48 beginning in the first quarter of 2007. The
      Company is currently in the process of determining the impact, if any, of
      adopting the provisions of FIN 48 on its financial position, results of
      operations and liquidity.




In
      September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements,” which
      defines fair value, establishes a framework for measuring fair value under
      other
      accounting pronouncements that permit or require fair value measurements,
      changes the methods used to measure fair value and expands disclosures about
      fair value measurements. In particular, disclosures are required to provide
      information on the extent to which fair value is used to measure assets and
      liabilities; the inputs used to develop measurements; and the effect of certain
      of the measurements on earnings (or changes in net assets). SFAS No. 157 is
      effective for fiscal years beginning after November 15, 2007 and interim periods
      within those fiscal years. Early adoption, as of the beginning of an entity’s
      fiscal year, is also permitted, provided interim financial statements have
      not
      yet been issued. The Company expects to adopt the provisions of FIN 48 beginning
      in the first quarter of 2008. The Company is currently evaluating the potential
      impact, if any, that the adoption of SFAS No. 157 will have on its consolidated
      financial statements.





In
      September 2006, the Securities and Exchange Commission issued Staff Accounting
      Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when
      Quantifying Misstatements in Current Year Financial Statements” (“SAB No. 108”).
      SAB No. 108 provides guidance on how prior year misstatements should be
      considered when quantifying misstatements in the current year financial
      statements. SAB No. 108 requires registrants to quantify misstatements using
      both a balance sheet and an income statement approach and evaluate whether
      either approach results in quantifying a misstatement that, when all relevant
      quantitative and qualitative factors are considered, is material. SAB No. 108
      does not change the guidance in SAB No. 99, “Materiality,” when evaluating the
      materiality of misstatements.





SAB
      No.
      108 is effective for fiscal years ending after November 15, 2006. Upon initial
      application, SAB No. 108 permits a one-time cumulative effect adjustment to
      beginning retained earnings. The Company adopted SAB No. 108 for the fiscal
      year
      ended December 31, 2006. Adoption of SAB No. 108 did not have a material impact
      on the consolidated financial statements.





In
      February 2007, the FASB issued SFAS No. 159, *The
      Fair Value Option for Financial Assets and Financial Liabilities* (“SFAS 159”).
      SFAS 159 allows entities to measure at fair value many financial
      instruments and certain other assets and liabilities that are not otherwise
      required to be measured at fair value. SFAS 159 is effective for fiscal
      years beginning after November 15, 2007. We have not determined what
      impact, if any, that adoption will have on our results of operations, cash
      flows
      or financial position.





**ITEM
      3 - CONTROLS AND PROCEDURES**





**Evaluation
      of Disclosure Controls and Procedures** .


As
      of March 31, 2007, the Company’s management carried out an evaluation, under the
      supervision of the Company’s President and the Chief Financial Officer of the
      effectiveness of the design and operation of the Company’s system of disclosure
      controls and procedures pursuant to the Securities and Exchange Act , Rule
      13a-15(e) and 15d-15(e) under the Exchange Act.  Based upon that
      evaluation, the President and Chief Financial Officer concluded that the
      Company’s disclosure controls and procedures were effective, as of the date of
      their evaluation, for the purposes of recording, processing, summarizing and
      timely reporting material information required to be disclosed in reports filed
      by the Company under the Securities Exchange Act of 1934.


11


**Changes
      in internal controls** .


There
      were no changes in internal controls over financial reporting, known to the
      President or Chief Financial Officer that occurred during the period covered
      by
      this report that has materially affected, or is likely to materially effect,
      the
      Company’s internal control over financial reporting.




















12







**PART
      II**




**Item
      1. Legal Proceedings**


None





**Item
      2. Changes in Securities**


None





**Item
      3. Defaults Upon Senior Securities**


None





**Item
      4. Submission of Matters to a Vote of Security Holders**


None





**Item
      5. Other Information**


None





**Item
      6. Exhibits**




On
      January 26, 2007, the Company reported on Form 8-K that, on January 24, 2007,
      the Company executed a definitive agreement to acquire ADAO Telecom, Inc.,
      a
      Florida based and privately held corporation (“ADAO”). ADAO, a telephony
      engineering and designs firm, specializes in the development of cellular
      technologies that target the low-end user market segment. In exchange for all
      of
      the shares of ADAO, the Company shall issue to the shareholders of ADAO
      73,500,000 ($0.0001 par value per share) restricted shares of the Company’s
      common stock equal to 53.3% of the outstanding shares. Pursuant to the
      agreement, the Company is to transfer $300,000 to ADAO, which is to be earmarked
      for the development of a prototype to be owned by the Company. We expect this
      transaction to close as soon as the 2 nd calendar
      quarter of 2007, but no later than May 30, 2007 (“Closing”). As further
      consideration, the Company shall, subsequent to the Closing, increase its
      authorized number of shares of common stock from 150,000,000 to 300,000,000
      and
      change its name to ADAO Wireless, Inc. At that time, ADAO will receive an
      additional 17,000,000 shares of the Company’s common stock. It is further agreed
      that subsequent to the Company raising its authorized shares, agents of the
      Company will make their best efforts to raise between $3,500,000 and $4,500,000
      prior to June 15, 2007.




Also
      on
      January 26, 2007, the Company reported on Form 8-K that, during discussions
      with
      Volius, Inc. (“Volius”), it became apparent to both Volius and the Company that
      it would be difficult, if not impossible, to agree on the amount of capital
      to
      be raised, the valuation of Volius and the timing of the ultimate transaction.
      Also during that period, the Company was introduced to ADAO and concluded that
      ADAO was a better fit with shareholders' goals of acquiring a business with
      dynamic opportunities. On January 18, 2007, the Company terminated its Letter
      of
      Intent to merge with Volius.




On
      February 27, 2007, the Company reported on Form 8-K that, on February 15, 2007,
      Organetix entered into non-exclusive agreements with Ambassador Thomas Graham,
      Jr., Mr. David Lewis and Mr. Aaron Foley to serve on the Corporation’s Board of
      Advisors. All shall serve as Advisors until the earlier of February 15, 2009
      or
      the date that any Advisor is removed from the Board. Ambassador Graham will
      serve as Chairman of the Board of Advisors. As compensation for participation
      on
      the Board of Advisors, Ambassador Graham received 2,000,000 shares of the
      Corporation’s common stock and Messrs. Lewis and Foley each received 500,000
      shares of the Corporation’s common stock. Subsequent to this filing, the
      Company’s agreement with Ambassador Graham was terminated by both parties.





31.1
      Certification of President


31.2
      Certification of Principal Financial Officer


32.1
      Certification of President


32.2
      Certification of Principal Financial Officer


13




**SIGNATURES**




In
      accordance with the requirements of the Exchange Act, the registrant caused
      this
      report to be signed on its behalf by the undersigned, thereunto duly authorized.







**ORGANETIX,
      INC.**




/s/
      Dr. David F. Hostelley


Name:
      Dr.
      David F. Hostelley


Title:
      President


Date:
      May
      21, 2007
























14